Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Cell and Gene Therapy Manufacturing Services Market Report 2024

Cell & Gene Therapy Manufacturing Services Global Market Report 2024 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Cell & Gene Therapy Manufacturing Services Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cell & Gene Therapy Manufacturing Services Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell & Gene Therapy Manufacturing Services Market Definition And Segments

Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services.

The main types of cell and gene therapy manufacturing services include gene therapy and cell therapy. Gene therapy is a medical strategy that addresses the underlying genetic issue in order to treat or prevent disease. They are used for commercial manufacturing and clinical manufacturing applications for various indications including central nervous system disorders, ophthalmology diseases, cardiovascular diseases, infectious diseases, orthopedic diseases and oncology diseases. These services are used by academic and research institutes, pharmaceutical and biotechnology companies, and others.

The cell & gene therapy manufacturing services market covered in this report is segmented –

1) By Type: Gene Therapy, Cell Therapy

2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases

3) By Application: Commercial Manufacturing, Clinical Manufacturing

4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from $7.25 billion in 2023 to $8.55 billion in 2024 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to increased R&D investments, regulatory support and frameworks, growing pipeline of cell & gene therapies, industry collaborations and partnerships, increasing global demand for personalized medicine.

The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $15.77 billion in 2028 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability.

Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth

The high incidence of cancer and other target diseases is expected to propel the growth of the cell and gene therapy manufacturing services market going forward. Cancer is a severe disorder in which the body's cells reproduce fast and uncontrollably, resulting in abnormal growth. Cell and gene therapies are developing as promising new strategies to combat the rising incidence of cancer, which is driving the demand for novel and efficient treatment choices. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. Therefore, the high incidence of cancer and other target diseases is driving the growth of the cell and gene therapy manufacturing services market going forward.

Rising Adoption Of Personalized Medicines To Drive Market Growth

The increasing adoption of personalized medicines is expected to propel the growth of cell and gene therapy manufacturing services market going forward. Personalized medicine is an innovative healthcare approach that tailor’s medical treatment and interventions to the individual characteristics of each patient. Personalized medicine enhances cell and gene therapy by tailoring treatments to an individual's unique genetic profile, enabling targeted therapies with optimized efficacy, reduced side effects, and improved patient outcomes. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the increasing adoption of personalized medicine is driving the growth of the cell and gene therapy manufacturing services market

Major companies operating in the cell & gene therapy manufacturing services market report are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd., Oxford Biomedica PLC, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics PLC, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market

Technological advancements are a key trend gaining popularity in the cell and gene therapy manufacturing services market. Major companies operating in the cell and gene therapy manufacturing services market are adopting new technologies to sustain their position in the market. For instance, in October 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company specializing in various preclinical and clinical laboratory, gene therapy, and cell therapy services, launched the navigation Vector Platform (navigation). It is a platform that simplifies the path to GMP Adeno-Associated Virus (AAV) vector manufacturing without requiring extensive process development. Compared to standard manufacturing workflows, the navigation platform can cut a program's timeframe to GMP by 55% for viral vector gene therapy researchers. Charles River's navigation technique is based on a unique high-productivity HEK293 suspension cell line that can be scaled up and serotyped to meet clients' needs.

Strategic Collaborations Drive Advancements In Cell And Gene Therapy Manufacturing Services Market

Major companies operating in the cell and gene therapy manufacturing services market are forming partnerships to develop new products and strengthen their positions in the market. Collaborations and partnerships in the cell and gene therapy manufacturing services market foster innovation, leverage complementary expertise, and accelerate the development and commercialization of advanced therapies by combining resources and capabilities. For instance, in January 2022, Allogene Therapeutics Inc., a US-based biotechnology company collaborated with Antion Biosciences SA, a Switzerland-based biopharmaceutical company, to advance multiplex gene silencing for the development of next-generation allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. The collaboration allows Allogene to deploy Antion's miCAR technology alongside other strategies to enhance immune evasion and advance allogeneic CAR T therapy, potentially creating more effective and tailored cell therapies.

Thermo Fisher Strengthens Global Presence In Cell And Gene Therapy With Acquisition Of Henogen SA

In January 2021, Thermo Fisher Scientific Inc., a US-based provider of scientific instrumentation, reagents, consumables, and software services, acquired Henogen SA for $880 million in cash. The acquisition would expand Thermo Fisher's global capacity for cell and gene therapies. In the viral vector sector, it continues enhancing its capabilities for cell and gene vaccines and therapeutics globally. The laboratory products and services division of Henogens would be integrated into Thermo Fisher's Pharma Services business. Henogen SA is a Belgium-based biomanufacturing company with development and manufacturing services.

North America was the largest region in the cell and gene therapy manufacturing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell & gene therapy manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell and gene therapy manufacturing services market includes revenues earned by cell and gene therapy manufacturing and related services which include analytical and process development, current good manufacturing practice cell therapy manufacturing services of autologous and allogeneic t-cells, natural killer cells, dendritic cells, mesenchymal stem cells, hematopoietic stem cells, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cell and gene therapy manufacturing services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy manufacturing services optical components market statistics, including cell and gene therapy manufacturing services optical components industry global market size, regional shares, competitors with a cell and gene therapy manufacturing services optical components market share, detailed cell and gene therapy manufacturing services optical components market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy manufacturing services optical components industry. This cell and gene therapy manufacturing services optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell & Gene Therapy Manufacturing Services Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $8.55 billion
Revenue Forecast In 2033 $15.77 billion
Growth Rate CAGR of 16.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Thermo Fisher Scientific Inc.; Merck KGaA; Charles River Laboratories International Inc.; Lonza Group AG; Catalent Inc.; WuXi AppTec; Takara Bio Inc.; Nikon Corporation; Fujifilm Holdings Corporation; F. Hoffmann-La Roche Ltd; Oxford Biomedica plc; CGT Catapult; bluebird bio Inc.; Boehringer Ingelheim International GmbH; Innovative Cellular Therapeutics Co. Ltd.; Samsung Biologics Co. Ltd.; Novartis International AG; Pfizer Inc.; Brammer Bio; AGC Biologics; Cognate BioServices Inc.; Paragon Bioservices Inc.; Merck KGaA operating as MilliporeSigma; Sarepta Therapeutics Inc.; Spark Therapeutics Inc.; Orchard Therapeutics plc; Precision BioSciences Inc.; PCT a Hitachi Group Company; Aldevron LLC; BioNTech SE
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cell & Gene Therapy Manufacturing Services Market Characteristics

    3. Cell & Gene Therapy Manufacturing Services Market Trends And Strategies

    4. Cell & Gene Therapy Manufacturing Services Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cell & Gene Therapy Manufacturing Services Market Size and Growth

    5.1. Global Cell & Gene Therapy Manufacturing Services Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cell & Gene Therapy Manufacturing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cell & Gene Therapy Manufacturing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cell & Gene Therapy Manufacturing Services Market Segmentation

    6.1. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gene Therapy

    Cell Therapy

    6.2. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Central Nervous System Disorders

    Ophthalmology Diseases

    Cardiovascular Diseases

    Infectious Diseases

    Orthopedic Diseases

    Oncology Diseases

    6.3. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Commercial Manufacturing

    Clinical Manufacturing

    6.4. Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Academic And Research Institutes

    Pharmaceutical And Biotechnology Companies

    Other End-Users

    7. Cell & Gene Therapy Manufacturing Services Market Regional And Country Analysis

    7.1. Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market

    8.1. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cell & Gene Therapy Manufacturing Services Market

    9.1. China Cell & Gene Therapy Manufacturing Services Market Overview

    9.2. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cell & Gene Therapy Manufacturing Services Market

    10.1. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cell & Gene Therapy Manufacturing Services Market

    11.1. Japan Cell & Gene Therapy Manufacturing Services Market Overview

    11.2. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cell & Gene Therapy Manufacturing Services Market

    12.1. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cell & Gene Therapy Manufacturing Services Market

    13.1. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cell & Gene Therapy Manufacturing Services Market

    14.1. South Korea Cell & Gene Therapy Manufacturing Services Market Overview

    14.2. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cell & Gene Therapy Manufacturing Services Market

    15.1. Western Europe Cell & Gene Therapy Manufacturing Services Market Overview

    15.2. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cell & Gene Therapy Manufacturing Services Market

    16.1. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cell & Gene Therapy Manufacturing Services Market

    17.1. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cell & Gene Therapy Manufacturing Services Market

    18.5. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cell & Gene Therapy Manufacturing Services Market

    19.9. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cell & Gene Therapy Manufacturing Services Market

    20.13. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cell & Gene Therapy Manufacturing Services Market

    21.1. Eastern Europe Cell & Gene Therapy Manufacturing Services Market Overview

    21.2. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cell & Gene Therapy Manufacturing Services Market

    22.1. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cell & Gene Therapy Manufacturing Services Market

    23.1. North America Cell & Gene Therapy Manufacturing Services Market Overview

    23.2. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cell & Gene Therapy Manufacturing Services Market

    24.1. USA Cell & Gene Therapy Manufacturing Services Market Overview

    24.2. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cell & Gene Therapy Manufacturing Services Market

    25.1. Canada Cell & Gene Therapy Manufacturing Services Market Overview

    25.2. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cell & Gene Therapy Manufacturing Services Market

    26.1. South America Cell & Gene Therapy Manufacturing Services Market Overview

    26.2. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cell & Gene Therapy Manufacturing Services Market

    27.1. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cell & Gene Therapy Manufacturing Services Market

    28.1. Middle East Cell & Gene Therapy Manufacturing Services Market Overview

    28.2. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cell & Gene Therapy Manufacturing Services Market

    29.1. Africa Cell & Gene Therapy Manufacturing Services Market Overview

    29.2. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape And Company Profiles

    30.1. Cell & Gene Therapy Manufacturing Services Market Competitive Landscape

    30.2. Cell & Gene Therapy Manufacturing Services Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck KGaA

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Charles River Laboratories International Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Lonza Group AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Catalent Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cell & Gene Therapy Manufacturing Services Market Competitive Benchmarking

    32. Global Cell & Gene Therapy Manufacturing Services Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cell & Gene Therapy Manufacturing Services Market

    34. Cell & Gene Therapy Manufacturing Services Market Future Outlook and Potential Analysis

    34.1 Cell & Gene Therapy Manufacturing Services Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cell & Gene Therapy Manufacturing Services Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cell & Gene Therapy Manufacturing Services Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Merck KGaA Financial Performance
  • Table 77: Charles River Laboratories International Inc. Financial Performance
  • Table 78: Lonza Group AG Financial Performance
  • Table 79: Catalent Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cell & Gene Therapy Manufacturing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Cell & Gene Therapy Manufacturing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Cell & Gene Therapy Manufacturing Services Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Merck KGaA Financial Performance
  • Figure 77: Charles River Laboratories International Inc. Financial Performance
  • Figure 78: Lonza Group AG Financial Performance
  • Figure 79: Catalent Inc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
COVID-19 Rapid Test Kits Market 2022 – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Test Components (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood, Others), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care, Others), And By Region, Opportunities And Strategies – Global Forecast To 2031
View Report
Central Lab Global Market Report 2024 – By Service Type (Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology or Histology, Specimen Management And Storage, Special Chemistry Services, Other Service Types ), By Test Type (Human And Tumor Genetics, Clinical Chemistry, Medical Microbiology And Cytology, Other Esoteric Tests), By End-User (Pharmaceutical Companies, Academic And Research Institutes, Biotechnology Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Architectural, Engineering Consultants And Related Services Global Market Report 2024 – By Type (Engineering Services, Architectural Services, Surveying & Mapping Services, Geophysical Services, Laboratory Testing Services, Building Inspection Services, Drafting Services), By Service Provider (Large Enterprise, Small And Medium Enterprise), By Application (Road, Rail, Port, Airport, Pipeline, Power, Other Application) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hospital Acquired Infections Testing Kits Global Market Report 2024 – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumonia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others), By Pathogen Type (Viral, Bacterial, Fungal), By Application (Drug Resistance Testing, Disease Testing) – Market Size, Trends, And Global Forecast 2024-2033
View Report
COVID-19 Detection Test Kits and Consumables Global Market Report 2024 – By Kits (Viral Load Testing Kits (qPCR and RT-PCR), Virus Neutralizing Assay Kits, Antibody Detection Kits (Elisa), Viral Antigen Detection Test Kits, Other Kits), By Consumables (Swabs, Tubes, Viral Transfer Media, Reagents, Other Consumables), By Specimen Type (Nose & Throat Swab, Blood, Sputum, Nasal Aspirate), By End Use (Hospitals, Clinics, Public Health Labs, Private And Commercial Labs, Physicians Labs, Research Institutes, Other End Uses) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report

Frequently Asked Questions

What is the definition of the cell and gene therapy manufacturing services market?

Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services. For further insights on the cell and gene therapy manufacturing services market, request a sample here

How will the cell and gene therapy manufacturing services market drivers and restraints affect the cell and gene therapy manufacturing services market dynamics? What forces will shape the cell and gene therapy manufacturing services industry going forward?

The cell and gene therapy manufacturing services market major growth driver - rising prevalence of cancer and other target diseases to drive market growth. For further insights on the cell and gene therapy manufacturing services market, request a sample here

What is the forecast market size or the forecast market value of the cell and gene therapy manufacturing services market ?

The cell & gene therapy manufacturing services market size has grown rapidly in recent years. It will grow from $7.25 billion in 2023 to $8.55 billion in 2024 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to increased r&d investments, regulatory support and frameworks, growing pipeline of cell & gene therapies, industry collaborations and partnerships, increasing global demand for personalized medicine. The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $15.77 billion in 2028 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to market maturation and commercialization, global expansion of biopharmaceutical manufacturing, increased outsourcing by pharma companies, advancements in automation and robotics, emergence of new therapeutic modalities. Major trends in the forecast period include rising demand for energy efficiency, advanced materials and technologies, compact and modular designs, electrification of transportation, focus on safety and reliability. For further insights on the cell and gene therapy manufacturing services market, request a sample here

How is the cell and gene therapy manufacturing services market segmented?

The cell and gene therapy manufacturing services market is segmented
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopaedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-UsersFor further insights on the cell and gene therapy manufacturing services market, request a sample here

Which region has the largest share of the cell and gene therapy manufacturing services market? What are the other regions covered in the report?

North America was the largest region in the cell and gene therapy manufacturing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the cell and gene therapy manufacturing services market, request a sample here.

Who are the major players in the cell and gene therapy manufacturing services market?

Major companies operating in the cell & gene therapy manufacturing services market report are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE For further insights on the cell and gene therapy manufacturing services market, request a sample here.

What are the key trends in the cell and gene therapy manufacturing services market?

Major trend in the cell and gene therapy manufacturing services market - technological advancements driving innovation in cell and gene therapy manufacturing services market. For further insights on the cell and gene therapy manufacturing services market, request a sample here.

What are the major opportunities in the cell and gene therapy manufacturing services market? What are the strategies for the cell and gene therapy manufacturing services market?

For detailed insights on the major opportunities and strategies in the cell and gene therapy manufacturing services market, request a sample here.

How does the cell and gene therapy manufacturing services market relate to the overall economy and other similar markets?

For detailed insights on cell and gene therapy manufacturing services market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cell and gene therapy manufacturing services industry?

For detailed insights on the mergers and acquisitions in the cell and gene therapy manufacturing services industry, request a sample here.

What are the key dynamics influencing the cell and gene therapy manufacturing services market growth? SWOT analysis of the cell and gene therapy manufacturing services market.

For detailed insights on the key dynamics influencing the cell and gene therapy manufacturing services market growth and SWOT analysis of the cell and gene therapy manufacturing services industry, request a sample here.